Canaccord Genuity Downgrades Bioceres Crop Solutions to Hold, Lowers Price Target to $2.5
Benzinga Newsdesk 1 year ago
NewsDowngradesPrice TargetAnalyst Ratings
Canaccord Genuity analyst Austin Moeller downgrades Bioceres Crop Solutions (NASDAQ:BIOX) from Buy to Hold and lowers the price target from $6.5 to $2.5.
Canaccord Genuity analyst Austin Moeller downgrades Bioceres Crop Solutions (NASDAQ:BIOX) from Buy to Hold and lowers the price target from $6.5 to $2.5.